Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Vatreptacog alfa (activated)

EU orphan designation number: EU/3/12/1030   
Active ingredient: Vatreptacog alfa (activated)
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Centralised Orphan - Designation EMA/OD/069/12 (2012)5794 of 09/08/2012